Creatinine Clearance (Cockcroft-Gault)
Estimates creatinine clearance from age, sex, weight and serum creatinine
4 items left
Formula
- Creatinine clearance (mL/min) = (140 - age in years) × weight (kg) ÷ (72 × serum creatinine in mg/dL)
- For females, multiply the result by 0.85
Cautions
- An estimate of creatinine clearance, not a measured value. The serum creatinine should reflect a steady state of renal function; the estimate is unreliable while kidney function is changing quickly.
- The tool applies the equation to the numbers entered, in kg and mg/dL, and does not convert units. Check the units on the laboratory report before entering the creatinine.
- The tool is limited to adults (18 years or older). It gives no category and no dosing advice; drug labels state which measure of renal function to use for dose adjustment.
- Creatinine-based estimates depend on muscle mass. In people with little muscle (sarcopenia, long bed rest, marked emaciation, limb amputation, thin older adults) they overestimate kidney function, and in people with a lot of muscle, such as athletes, they underestimate it. In obese people the Cockcroft-Gault estimate overestimates kidney function. When muscle mass is not typical, consider an equation based on cystatin C.
- The Cockcroft-Gault equation was derived with serum creatinine measured by the Jaffe method. Enzymatic and Jaffe measurements differ somewhat, so a value from a different assay can shift the estimate.
- The result is a creatinine clearance in mL/min and is not adjusted for body surface area. It is not the same quantity as an eGFR from another equation.
References
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. (original not seen) PMID: 1244564, DOI: 10.1159/000180580[Original article]
- Cefepime Injection in Galaxy Container, prescribing information. U.S. Food and Drug Administration; revised 7/2025. (Section 2.3 Dosage Adjustments in Patients with Renal Impairment (the Cockcroft-Gault equation, males and females); section 15 References) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/050817s012lbl.pdf[Package insert]
- Japanese Society of Nephrology, ed. Evidence-based Clinical Practice Guideline for CKD 2023 (in Japanese; English title translated by the authors of this site). Tokyo: Tokyo Igakusha; 2023. (Chapter 1, 1-2-1 (pp. 5 to 6)) https://jsn.or.jp/data/gl2023_ckd_ch01.pdf[Guideline]
- Japanese Society of Nephrology, ed. CKD Practice Guide 2024 (in Japanese; English title translated by the authors of this site). Tokyo: Tokyo Igakusha; 2024. (Chapter 12, pp. 1 to 2) https://jsn.or.jp/data/gl2024_ckd_ch12.pdf[Guideline]
Checked on: 2026-11-07
Disclaimer
This calculation is intended to support the judgment of healthcare professionals. Results are for reference only; decisions about diagnosis and treatment must be made by the responsible healthcare professional. The values you enter never leave your device.